BRAIN BIOTEC NA O.N./ DE0005203947 /
9/20/2024 2:56:59 PM | Chg. -0.13 | Volume | Bid2:56:59 PM | Ask2:56:59 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
1.46EUR | -7.89% | 29,503 Turnover: 43,932.78 |
1.43Bid Size: 1,700 | 1.46Ask Size: 2,200 | 29.72 mill.EUR | 0.00% | - |
Fundamentals
FY 2021 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | -0.25 EUR | -51.92% |
EPS Diluted: | -0.25 EUR | -51.92% |
Revenues per Share: | 2.04 EUR | -2.86% |
Book Value per Share: | 1.95 EUR | 74.52% |
Cash Flow per Share: | -0.20 EUR | -23.99% |
Dividend per Share: | 0.00 EUR | - |
Total | in mill. | |
Revenues: | 40.70 EUR | 3.83% |
Net Income: | -5.00 EUR | -48.45% |
Operating Cash Flow: | -3.90 EUR | - |
Cash and Cash Equivalents: | 24.50 EUR | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | - | - |
P/S Ratio: | 0.73 | 4.86 |
P/BV ratio: | 0.77 | 5.10 |
P/CF Ratio: | -7.62 | -50.73 |
PEG: | 0.11 | - |
Earnings Yield: | -16.78% | -2.52% |
Dividend Yield: | 0.00% | 0.00% |
Market Capitalization | ||
Market Capitalization: | 29.72 mill. EUR | 197.83 mill. EUR |
Free Float Market Cap.: | 14.06 mill. EUR | 93.58 mill. EUR |
Market Cap. / Employee: | 103,177.3264 EUR | 686,925.5556 EUR |
Shares Outstanding: | 21.85 mill. |
Profitability
Gross Profit Margin: | 58.72% |
EBIT Margin: | -15.97% |
Net Profit Margin: | -12.29% |
Return on Equity: | -12.89% |
Return on Assets: | -6.44% |
Financial Strength
Liquidity I / Cash Ratio: | 216.81% |
Liquidity II / Quick Ratio: | 216.81% |
Liquidity III / Current Ratio: | 346.02% |
Debt / Equity Ratio: | 100.26% |
Dynam. Debt / Equity Ratio: | -997.44% |
Efficiency
Employees: | 288 |
Personal Expenses / Employee: | 67,708.33 EUR |
Revenues / Employee: | 141,319.44 EUR |
Net Income / Employee: | -17,361.11 EUR |
Total Assets / Employee: | 269,791.67 EUR |
* Fiscal Year End: | 9/30/2021 |
Accounting Standard: | IFRS |
Currency: | EUR |